Connect with us

Health

Nigeria to Begin Malaria Vaccine Trials in Six Weeks—NAFDAC DG

Published

on

Mosquirix Malaria Vaccine

By Adedapo Adesanya

The Director General of the National Agency For Food and Drug Administration and Control (NAFDAC), Mrs Mojisola Adeyeye, has said the approval process for the R21/Matrix-M malaria vaccine requires more clinical trials before its full use.

She made this disclosure on Wednesday morning while speaking on Channels Television.

In her words, “The clinical trial will begin within the next six weeks. The RTS,S did not include Nigeria, because from the beginning the effectiveness was 30 per cent, so we did not agree to join the clinical trial.”

Mrs Adeyeye noted that development in a country’s governance is a contributing factor to the persistence of malaria in Africa.

She also stated that the provision of the vaccine is important for transmission prevention, adding that NAFDAC is going to do its own test, trials and levels of approval.

“For the R21, after reading the dossier, I believe Nigeria should join. This is because we have a high probability of success. If something is 75 per cent effective from the beginning, then we know they are very likely to be successful. It has 75 per cent effectiveness for a malaria vaccine, which is great.

Mrs Adeyeye noted that phase four clinical trials would be conducted and more laboratory work.

“However, it is not what is written only that we know as the efficacy; we have to check every line of the dossier to ensure that science speaks. This is science-driven. What we did was to have two sets of reviews,” she said.

According to her, for the first time in the agency’s history, NAFDAC is going to have an external expert body for phase four.

“We are going to do phase four clinical trials; it should be tested in our country. We are going to do more observation. This would involve more laboratory works, this cannot be administered until it goes through a testing process in the country before the transmission process,” Mrs Adeyeye disclosed.

The NAFDAC DG stated that the vaccination focus is mainly on children and not adults, adding that this was the limitation the RTS,S malaria vaccine had in its percentage efficacy.

“Even if it is only 30 per cent of the children that will not die or the death would be prevented, that will be good enough. But we didn’t take that up as an agency to be part of the trial. This particular R21 had been submitted to WHO, and they are going to be doing their own review,” she said.

“NAFDAC approved the R21 vaccine for children under five, specifically for those under three years. NAFDAC tested the second vaccine (RTSS), and it was not found effective enough. Nigeria is part of this one, that is R21; we gave provisional approval after a very rigorous approval process.”

In a related development, the world celebrated World Malaria Day yesterday (April 25) and the World Health Organisation (WHO) called on African leaders to increase their investment in health as part of efforts to rapidly reduce the burden of malaria and save the lives of its populations.

WHO Country Representative in Nigeria, Mr Walter Mulombo, made the appeal at a media roundtable to commemorate the 2023 World Malaria Day (WMD) in Abuja on Tuesday.

Mr Mulombo said malaria intervention, like any other health intervention,, should not be seen as a burden for the government or partners but as an enabling factor for social economic development.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

1 Comment

Leave a Reply

Health

Sault Tribe Enacts Smoking Ban in Kewaunee

Published

on

Ban smoking Sault Tribe

Health and comfort have become increasingly essential issues lately, and this has not gone unnoticed in entertainment venues. The Sault Tribe, which operates the Kewadin Casino, has decided to ban smoking in five gambling establishments. This innovation is aimed at creating a healthier environment for all visitors and employees.

Health and comfort come first

Tribal representatives emphasized that people’s health is their top priority. The decision to ban smoking was a logical step toward positive change. “As a tribal government, we are focused on improving health, and the move to ban smoking in casinos is the right step forward,” notes one tribal speaker. This means caring about the health of visitors and the well-being of the employees who work in these facilities daily.

The Sault Tribe has been actively gathering opinions from its customers and employees, and the results have been unequivocal: many are in favor of banning smoking. “We have heard from many customers and employees that a smoking ban is the right step forward,” states a tribal spokesperson. Such feedback confirms that concern for health and well-being is becoming increasingly important to the gambling industry.

What will change at Kewadin casinos?

In the weeks following the passage of the amendments, Kewadin casinos located in Sault Ste. Marie, St. Ignace, Manistique, Christmas, and Hessel will begin implementing the new policy. The smoking ban will be in effect in all establishments, including gaming rooms, restaurants, and recreational facilities. This approach will not only make the casino experience more enjoyable for non-smoking visitors, but it will also create a safer environment for employees who spend much time in the gaming rooms.

Positive implications for business and society

The adopted initiative will not only bring health benefits but will also affect the success of businesses in the long run:

  • The actions taken also emphasize the Sault Tribe’s social responsibility. They are not just in business but also show concern for the well-being of their customers and employees, making them an example for other gambling establishments.
  • Banning smoking in Kewadin casinos will create a more pleasant environment for both non-smokers and those looking to quit smoking. Smoking in public places often makes other visitors uncomfortable, and this move will help eliminate the unpleasant odour and smoke, thus creating a more pleasant atmosphere throughout the gaming rooms, restaurants, and other recreational areas.
  • The changes may attract a new audience interested in entertainment but previously avoided visiting casinos because of the smoking environment. This can lead not only to an increase in the number of guests but also, as a result, to increased profits for the establishment.

At the same time, avid smokers, which are still quite a lot, will be less likely to visit land-based casinos, where they are forbidden to relax in the usual way. Especially since today, they do not have to visit these establishments to satisfy their gambling needs.

Analyzing the search engine allows you to quickly find many popular operators, including 1win, with the largest number of gambling entertainment. And you can access these games without having to leave home. To register on 1win, it is enough to fill in a few fields in the appropriate window and develop a password. It takes less than a minute to do this and deposit money into your account. Moreover, most of the games can be played in a free demo.

Chippewa Tribe aims to create a “smoke-free” space that combines a healthy environment with the opportunity to relax and enjoy gambling. The new approach to business reflects and supports global trends aimed at caring for public health and reducing the negative impact of tobacco smoke on the health of others.

Recall that earlier, scientists told us about the new harm of smoking. According to new data, the negative impact of this bad habit on the immune system persists for several years after a person quits smoking.

Continue Reading

Health

SpecSMART Eye Clinic Takes Affordable, Quality Care to Ikeja, Environs

Published

on

SpecSMART Eye Clinic

By Modupe Gbadeyanka

The dream of residents of Ikeja and its environs enjoying affordable and quality care has now become a reality as a result of the opening of a new branch of SpecSMART Eye Clinic in the Opebi area of the capital of Lagos State.

SpecSMART Eye Clinic, a leading provider of optometry services in Lagos, commenced operations in Nigeria’s commercial capital in 2022.

Since then, it has been offering top-notch eye care to residents of the metropolis, especially those living on the Island. It has built a strong reputation for delivering high-quality primary eye care and optical products.

However, to extend its services to Lagosians living on the Mainland, it has now opened a new branch in Ikeja, reinforcing its commitment to providing accessible, affordable eye care to a wider community.

Business Post gathered that the clinic’s state-of-the-art services are supported by a team of skilled optometrists and opticians, utilizing cutting-edge digital equipment.

The new Ikeja location will offer a wide range of services, including Automated Eye Examinations using advanced digital equipment for precise diagnosis and personalized care.

In addition, clients will enjoy on-the-spot lens glazing for single vision, bifocals, and varifocals, with additional lens coatings, with services to be rendered seven days a week from 9 am to 9 pm on Mondays to Saturdays, and on Sundays and public holidays from 10 am 7 pm.

Also, the clinic has over 950 frames, ranging from affordable home brands to premium designer options, priced from N18,000, and has flexible appointment scheduling with 24-hour online booking via SpecSMART’s website.

The facility has partnerships with leading HMO providers in the country and offers glaucoma management and other essential eye health services.

According to the company, its introductory packages start from N30,000 and include consultation, frame, and single-vision lenses.

“With the opening of our Ikeja branch, we are ready to serve more individuals who need accessible, cost-effective, and reliable eye care.

“Our aim is to create a positive impact in Nigeria’s optometry sector by combining advanced technology with a patient-centred approach,” the Practice Head and Medical Director of SpecSMART, Dr Adaeze Nwoko, stated.

Continue Reading

Health

FG Begins Vaccination Against Mpox in FCT, Six States

Published

on

Monkeypox mpox

By Adedapo Adesanya

The Federal Ministry of Health and Social Welfare through the National Primary Health Care Development Agency (NPHCDA) has commenced the vaccination against Monkeypox, now known as Mpox.

Business Post reports that Bayelsa, Rivers, Cross River, Akwa Ibom, Enugu, Benue, and the Federal Capital Territory, were selected as pilot states for the vaccination.

An average of 631 persons are expected to be vaccinated across the seven states with two doses of the Mpox vaccine. A buffer for 50 persons will be kept at the national in case of an upsurge in other states.

NPHCDA in a statement posted on its verified X account confirmed the exercise, stressing that the vaccination will help to protect communities and safeguarding health of the people.

In a related development, according to the latest update by the Nigeria Centre for Disease Control (NCDC), there are 1,442 suspected cases of Mpox from 36 states and the Federal Capital Territory, while the number of confirmed cases of the infection was 118 from 28 states and the FCT.

“To prevent the spread of Mpox, we strongly advise the public to avoid contact with animals that may carry the virus, including sick or dead animals in affected areas, avoid handling materials that have been in contact with infected animals, limit unnecessary physical contact with individuals who are infected, practice frequent handwashing with soap and water, and ensure that animal food products are thoroughly cooked before eating.

“It’s also important to use protective clothing and gloves when handling sick animals or their tissues. Similarly, health workers are advised to follow standard safety protocols including droplet precautions when treating patients, use protective equipment including masks, gloves, and gowns, during patient care, and be vigilant for symptoms of Mpox, especially fever and rash, among other measures.”

Continue Reading

Trending